NCT00512330|Unknown
Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB)
Evaluation of Urine Lipoarabinomannan ELISA In Diagnostics of Childhood Tuberculosis
Loading search results
Evaluation of Urine Lipoarabinomannan ELISA In Diagnostics of Childhood Tuberculosis
Sponsor study identifier
observational
250
1 country
1
Study Start
August 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
August 2008
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
In children, it remains quite difficult even in developed countries, to prove a diagnosis of Tuberculosis (TB). New means for diagnosis of this disease are currently being researched. One candidate test is Lipoarabinomannan ELISA from Urine, which has shown good sensitivity of up to 80% in adults. Our study aims to evaluate this test in the diagnosis of children with TB.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2008
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2007
Date type not reportedThis date has not been verified as actual or estimated.
August 6, 2007
Actual (reported)August 7, 2007
Actual (reported)August 2008
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Children up to 14 years of age with suspicion of TB
Contact the study team to confirm eligibility.
Our Lady of Mount Carmel Hospital
Kapiri/Mchinji, Mchinji, Malawi
Norbert Heinrich, MD
University of Bonn
John Chimphamba, Clinical Officer
Our Lady of Mount Carmel Hospital, Kapiri
Andreas Mueller, PD Dr med.
University of Bonn
First Submitted
August 6, 2007
First Posted
August 7, 2007
Study Start
August 2007
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
August 2008
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis (TB) Subunit Vaccine in Purified Protein Derivative (PPD) Positive Volunteers
Last Updated
August 6, 2008
Record last verified: 2008-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: